Navigation Links
LA BioMed study finds hormone therapy increases frequency of abnormal mammograms, breast biopsies
Date:2/25/2008

TORRANCE Combined hormone therapy appears to increase the risk that women will have abnormal mammograms and breast biopsies, and it may decrease the effectiveness of both methods for detecting breast cancer, according to a report in the Feb. 25 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Rowan T. Chlebowski, M.D., Ph.D., a lead investigator at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), was the lead author of the report. He and his colleagues studied 16,608 post-menopausal women who participated in the Womens Health Initiative (WHI) clinical trial, a 15-year study that began in 1993.

The research team examined the effect of combined hormone therapy on breast cancer detection over five years and found it resulted in more than one in 10 women having otherwise avoidable mammogram abnormalities and one in 25 women having breast biopsies. Combined hormone therapy also compromised the diagnostic performance of mammograms and breast biopsies.

These findings represent a concern for post-menopausal women who are considering hormone therapy, said Dr. Chlebowski. They should take the results of this study into consideration and consult with their physicians before undergoing even short-term hormone therapy.

The study examined the use of conjugated equine estrogens plus medroxyprogesterone acetate for approximately five years. A total of 8,506 women were randomly assigned to receive a combination of estrogen (0.625 milligrams of conjugated equine estrogens per day) plus progesterone (2.5 milligrams of medroxyprogesterone acetate per day), while 8,102 took a placebo. Each woman received a mammogram and breast examination yearly, with biopsies performed based on physicians clinical judgment.

During the 5.6 years of the study, 199 women in the combined hormone group and 150 women in the placebo group developed breast cancer. Mammograms with abnormal result
'/>"/>

Contact: Laura Mecoy
Lmecoy@issuesmanagement.com
310-546-5860
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
Source:Eurekalert

Page: 1 2

Related medicine news :

1. BioMed Realty Trust Joint Venture Enters Into New $245 Million Construction Loan and Extends Term of Existing Loan Facility
2. Dr. Inder Verma named recipient of 2008 Vilcek Prize in biomedical science
3. 7th Annual Wiley Prize in Biomedical Sciences Awarded to Dr. Richard P. Lifton
4. Lung Cancer Alliance Urges Inclusion of $5 Billion for Biomedical Research in Economic Stimulus Package
5. BioMed Central bolsters radiology image collection
6. New nanotube findings by Stanford researchers give boost to potential biomedical applications
7. American Red Cross Announces New Leader for Biomedical Services
8. XCPT(TM) Patient Engagement and Communication Software Signs Representation Agreement with Lifecore Biomedical, Inc. (Nasdaq: LCBM)
9. BioMed Realty Trust Declares Fourth Quarter 2007 Common Stock and Preferred Stock Dividends
10. LA BioMed researchers find few emergency rooms fully equipped for pediatric patients
11. LA BioMed research finds simpler way to assess breast cancer risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...all/ -- Heska Corporation,(Nasdaq: HSKA ) today... of,Security Analysts, 12th Annual Biotech and Sp...1177 Avenue of the Americas, 2nd Floor in New York...:35 a.m. Eastern Time (7:35 a.m.,Mountain Time) a...weeks,following the presentation through a link u...
(Date:11/21/2008)...ique to combat cancer, study says, , ,...archers have discovered that some cancer cells use...ight lead to new treatments that starve and kill t...ells in the body need to produce energy. They do t...uires oxygen. Compared with normal cells, tumor ce...
(Date:11/21/2008)...ire/ -- U.S. News & World Report and the Natio...BlueChoice(R) HealthPlan of South Carolina in the ...ished in U.S. News & World Report,s issue this...ks the nation,s best health plans based on clinica...ion scores. NCQA and U.S. News & World Report ...
(Date:11/21/2008)...production of neural stem cells , , FRID...mice, exercise appears to reverse the decline in t...h aging, Taiwanese researchers report. , This r...ave off aging appears to be due to exercise,s abil...or the production of new brain cells. , "As we...
Breaking Medicine News(10 mins):Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:Exercise Keeps the Brain Young 2
...d villages have given birth to babies with eyesigh...med the air and water pollution //caused by coal m... Giridih district, around 200 km from here, were b...Saturday. The babies were admitted to an eye hospi...
...t outbreak of Avian Influenza in Pakistan. // In v...th-Western States bordering Pakistan were immediat...g areas especially to check informal/illegal trade...livestock and livestock products; intensify animal...
...ce and Medicine in Cricket (WCSMC), which is endor...as hosted in Barbados from the 4th to 7th April 20...ne consultant at the Manipal Hospital, Bangalore i... conference as a faculty from India. These scie...
... concerns of successive Australian governments, a ...on says //that the health of aborigines lags an ap...Aboriginal and Torres Strait Islander people have ...an their fellow countrymen on every indicator of h...
Other Medicine News:Health News:Women Deliver Babies With Eye Defects in Jharkhand Villages 2Health News:Steps To Prevent Out-Break Of Bird Flu 2Health News:Steps To Prevent Out-Break Of Bird Flu 3Health News:Cricket Science and Medicine Congress in Barbados 2Health News:Cricket Science and Medicine Congress in Barbados 3Health News:Cricket Science and Medicine Congress in Barbados 4Health News:Cricket Science and Medicine Congress in Barbados 5Health News:Aborigines Century Behind the Health of Colonizers, WHO Report 2
(Date:11/20/2008)...N, Nov. 20 PAREXEL Inter...global biopharmaceutical services provider, today ...ru to provide regulatory consulting and clinical r...u office, PAREXEL now has locations throughout fiv...rica, which also include Argentina, Brazil, Chile,...
(Date:11/19/2008)... , Study did not achieve statistical significa...FirstCall/ -- Pharmos Corporation (Nasdaq: PARS ...al trial of its topical NanoEmulsion (NE) drug del...thanolamine. , , The multi-center, randomiz...ated the safety and efficacy of the Company,s 3% D...
(Date:11/19/2008)...gers $5 Million Payment from Roche- , , MON...ory Pharmaceuticals Corp. (Nasdaq: MEMY ) today ... for its Phase 2 trial of R3487/MEM 3454, its lead...impairment associated with schizophrenia (CIAS). ...se 2 trial, triggering a $5.0 million payment from...
(Date:11/18/2008)...OWNE, Va., Nov. 18 Fort...hered at a November national forum to consider cut...blic health and national economy from outbreaks of...unced today. , , Among those innovations: ,...y American kitchen table that detects highly conta...
Breaking Medicine Technology:PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Chrysler Goes Holistic to Revolutionize Back Pain Care in the Workplace 11973 1Chrysler Goes Holistic to Revolutionize Back Pain Care in the Workplace 11973 2Chrysler Goes Holistic to Revolutionize Back Pain Care in the Workplace 11973 3New study shows extent of harmful human influences on global ecosystems 11971 1New study shows extent of harmful human influences on global ecosystems 11971 2Cell phone cancer link found by Tel Aviv University scientist 11969 1Cell phone cancer link found by Tel Aviv University scientist 11969 2Choking Game Turned Deadly for 82 Youths 11967 1Choking Game Turned Deadly for 82 Youths 11967 2Choking Game Turned Deadly for 82 Youths 11967 3
ACL 1000 is an affordable solution for low volume workloads, or as a backup analyzer. The test menu includes a variety of clotting assays, such as Lupus and APCR-V Leiden. The ACL 1000 also offers ba
The SYNCHRON CX4-S system consolidates DATs, TDMs and other esoteric tests in one workstation, targeted to the mid-size lab that processes 50-200 samples per day. Like all SYNCHRON CX super systems,
It takes powerful technology to increase laboratory efficiency and worker safety, and still lower costs. It takes the new SYNCHRON LX20 PRO, offering features that you will not find on any other chem
The leading fully automated system for plasma protein determinations. Third generation nephelometer combines reliability with highly cost-effective performance.
Medicine Products: